Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leila S Hojat
Sujit Suchindran

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2026
Start, Stop & Select: The Steward's Hat TrickLeila S Hojat, Sujit Suchindran
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 7, 2026
Real-world evaluation of ceftriaxone-related safety events: a stewardship call to actionKristen Paciullo, Sujit Suchindran, Leila S Hojat, et al.
Therapeutic Advances in Infectious Disease|February 21, 2022
Breaking down the barriers to health equityLeila S Hojat
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2026
Another Point Goes to Team Short Course: Implications of the BALANCE Trial Post-Hoc Analysis for Pseudomonas aeruginosa Bloodstream InfectionsLeila S Hojat, Emily S Spivak
Plos One|May 15, 2009
Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic reviewSujit Suchindran, Emily S Brouwer, Annelies Van Rie
AIDS and Behavior|October 22, 2008
Factors associated with HIV testing among public sector clinic attendees in Johannesburg, South AfricaAudrey Pettifor, Catherine MacPhail, Sujit Suchindran, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|June 4, 2026
Why we do what we do: a survey of ID providers about oral antibioticsMildred Nelson, Marisa Winkler, Sujit Suchindran, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 6, 2025
The hidden economic and environmental costs of antimicrobial therapies: a call to actionMildred Nelson, Sarah B Green, Sujit Suchindran, et al.
Microbiology Spectrum|November 6, 2025
Combating resistant pathogens: exploring the efficacy of eravacycline utilization in multidrug-resistant infectionsKiara Patino, Ryan Vathy, Ben Albrecht, et al.
Best Practice & Research. Clinical Haematology|December 9, 2022
Prevention and treatment of COVID-19 in patients with benign and malignant blood disordersElie A Saade, Leila S Hojat, Praveen Gundelly, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2026
Start, Stop & Select: The Steward's Hat TrickLeila S Hojat, Sujit Suchindran
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 7, 2026
Real-world evaluation of ceftriaxone-related safety events: a stewardship call to actionKristen Paciullo, Sujit Suchindran, Leila S Hojat, et al.
Therapeutic Advances in Infectious Disease|February 21, 2022
Breaking down the barriers to health equityLeila S Hojat
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2026
Another Point Goes to Team Short Course: Implications of the BALANCE Trial Post-Hoc Analysis for Pseudomonas aeruginosa Bloodstream InfectionsLeila S Hojat, Emily S Spivak
Plos One|May 15, 2009
Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic reviewSujit Suchindran, Emily S Brouwer, Annelies Van Rie
AIDS and Behavior|October 22, 2008
Factors associated with HIV testing among public sector clinic attendees in Johannesburg, South AfricaAudrey Pettifor, Catherine MacPhail, Sujit Suchindran, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|June 4, 2026
Why we do what we do: a survey of ID providers about oral antibioticsMildred Nelson, Marisa Winkler, Sujit Suchindran, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 6, 2025
The hidden economic and environmental costs of antimicrobial therapies: a call to actionMildred Nelson, Sarah B Green, Sujit Suchindran, et al.
Microbiology Spectrum|November 6, 2025
Combating resistant pathogens: exploring the efficacy of eravacycline utilization in multidrug-resistant infectionsKiara Patino, Ryan Vathy, Ben Albrecht, et al.
Best Practice & Research. Clinical Haematology|December 9, 2022
Prevention and treatment of COVID-19 in patients with benign and malignant blood disordersElie A Saade, Leila S Hojat, Praveen Gundelly, et al.
Pageof 4